Allopurinol for Gout
Links shared publicly online about this topic
Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients - Drugs.com MedNews
drugs.com — “Adding RDEA594 to Allopurinol Achieved Up to 89 Response Rate in Patients Who Failed to Achieve Target Response on Allopurinol Alone Conference Call and Webcast” View full resource at drugs.com
Most Recently Shared on January 10, 2011 at 8:16 pm By:
Drugs and Devices OW OW Health
Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopu... http://bit.ly/eRRRFu #drug
Gout, allopurinol use, and outcomes among HF patients | theheart.org
theheart.org — “Canadian researchers have shown for the first time that a history of gout is associated with an increased risk of rehospitalization or death in heart failure patients. Among those who had had gout, the use of allopurinol was associated with improved outcomes.” View full resource at theheart.org
Most Recently Shared on August 9, 2010 at 8:24 pm By:
History of gout linked to HF risk; allopurinol attenuates this: Canadian researchers have shown for the first time... http://bit.ly/8ZuOrF
Allopurinol Still Deemed First Line for Gout : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on May 3, 2011 at 9:13 pm By:
Miriam E. Tucker Patient Expert
RT @IntMedNews: Allopurinol Still Deemed First Line for #Gout http://bit.ly/mFkBMl
Ask the Expert: Allopurinol vs febuxostat
secure.quantiamd.com — “QuantiaMD is proud to have Ronald Rapoport answer your allopurinol and febuxostat questions.” View full resource at secure.quantiamd.com
Most Recently Shared on June 24, 2011 at 10:10 pm By:
QuantiaMD Support and Health Social Media
Rheumatology Expert Challenge: Allopurinol vs. Febuxostat? Ronald Rapoport compares these gout agents in 120 seconds http://ow.ly/5mPqN
BioCryst Initiates A Phase 2 Study Of BCX4208 Alone And In Combination With Allopurinol In Patients With Gout
medicalnewstoday.com — “BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) announced it is initiating a Phase 2 study of BCX4208 alone and in comb” View full resource at medicalnewstoday.com
Most Recently Shared on June 3, 2010 at 11:29 am By:
BioCryst Initiates A Phase 2 Study Of BCX4208 Alone And In Combination With Allopurinol In Patients With Gout: Bio... http://mnt.to/f/3Drg
Allopurinol--an old drug to prevent gout--limits angina symptoms
theheart.org — “A 40-year-old gout drug has been shown to have anti-ischemic properties and could be an alternative new treatment for the symptoms of chronic stable angina, say British researchers.” View full resource at theheart.org
Most Recently Shared on June 8, 2010 at 5:38 pm By:
James Beckerman, MD Internist, Cardiologist, Physician, and Doctor
New data: 40 year old gout drug may help with cardiac chest pain. http://www.theheart.org/article/1086007.do
BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined With Allopurinol In Patients With Gout
medicalnewstoday.com — “BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has announced positive top-line results from its randomized, double-blind, multi-center, placebo-controlled Phase 2 study designed to evaluate the ura” View full resource at medicalnewstoday.com
Most Recently Shared on September 19, 2010 at 12:05 pm By:
BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined With Allopurinol In Patients With Gout http://mnt.to/3JYH
Study: Cheap gout drug allopurinol shows promise in kidney disease http://bit.ly/cIPOii - Second study in a few days on allopurinol. #health
reuters.com — “Study: Cheap gout drug allopurinol shows promise in kidney disease http://bit.ly/cIPOii - Second study in a few days on allopurinol. #health” View full resource at reuters.com
Most Recently Shared on June 11, 2010 at 12:00 pm By:
Hisham Rana, MD Doctor and Physician
Study: Cheap gout drug allopurinol shows promise in kidney disease http://bit.ly/cIPOii - Second study in a few days on allopurinol. #health
BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients
news-medical.net — “BioCryst Pharmaceuticals, Inc. today announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone.” View full resource at news-medical.net
Most Recently Shared on December 22, 2010 at 12:13 pm By:
BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients: BioCryst Pharmaceuticals, In... http://bit.ly/gxbdgQ
Additional Results From A Phase 2b Study Of Lesinurad In Combination With Allopurinol
medicalnewstoday.com — “Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that additional positive clinical and preclinical results from its development program of lesinurad, the Company's lead product candidate for” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2011 at 3:06 pm By:
Additional Results From A Phase 2b Study Of Lesinurad In Combination With Allopurinol http://mnt.to/3WpY #gout
Rheumatology Article | Gout
mdlinx.com — “Febuxostat Efficacy in Allopurinol-Resistant Tophaceous Gout” View full resource at mdlinx.com
Most Recently Shared on June 9, 2011 at 10:10 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Febuxostat Efficacy in Allopurinol-Resistant Tophaceous Gout: Journal of Clinical Rheumatology (JCR) http://bit.ly/kLSjKl #Rheumatology
Family Medicine Article | Gout
mdlinx.com — “Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions” View full resource at mdlinx.com
Most Recently Shared on July 12, 2011 at 4:30 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse re... http://bit.ly/pbzsgn #FamPractice
Rheumatology Article | Gout
mdlinx.com — “Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions” View full resource at mdlinx.com
Most Recently Shared on July 12, 2011 at 6:39 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse r... http://bit.ly/r2CMTf #Rheumatology
BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined with Allopurinol in Patients with Gout - Drugs.com MedNews
drugs.com — “Top-line Results to be Discussed During Investor Day Meeting Today Sep 16, 2010 - BioCryst Pharmaceuticals, Inc. (NASDAQ BCRX) today announced positive top-line” View full resource at drugs.com
Most Recently Shared on September 16, 2010 at 1:15 pm By:
Drugs and Devices OW OW Health
BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined with Allopurinol in Patients with ... http://bit.ly/93i0ZV #drug
New Gout Drug Gets FDA Panel Nod
webmd.com — “Uloric should be the first new gout drug to be approved in over 40 years, an FDA expert panel recommends.” View full resource at webmd.com
Most Recently Shared on November 24, 2008 at 11:21 pm By:
WebMD Health News New Gout Drug Gets FDA Panel Nod: Uloric should be the first new go.. http://tinyurl.com/5p8k2v
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Miriam E. Tucker
Medical & public health journalist / Diabetes patient-expert / Senior Writer with Elsevier's International Medical News Group (@MedicalNewsNet).
Advertisement
